How are IRA, 340B, and Medicaid squeezing community oncology practices?

Community oncology is being framed as under simultaneous pressure from the Inflation Reduction Act, 340B dynamics, and Medicaid reimbursement. The article suggests the combined effect could tighten provider margins, reshape site-of-care economics, and complicate planning for payers, PBMs, manufacturers, and oncology operators.